Legis Daily

To require a study and report on policy and regulatory changes that may have contributed to the opioid epidemic.

USA115th CongressHR-5914| House 
| Updated: 5/22/2018
Mark Meadows

Mark Meadows

Republican Representative

North Carolina

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill requires the Government Accountability Office to report on health care policy changes that may have contributed to the rise in opioid overdoses and deaths over the last 10 years. The report must include an examination of: federal decisions relating to pain management strategies, state prescription drug monitoring programs, prescribing limitations, and pain medications with and without abuse-deterrent formulations.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 22, 2018
Introduced in House
May 22, 2018
Referred to the House Committee on Energy and Commerce.
  • May 22, 2018
    Introduced in House


  • May 22, 2018
    Referred to the House Committee on Energy and Commerce.

Health

Related Bills

  • HR 115-4482: To deter opioid abuse and addiction, to establish additional registration requirements for prescribers of opioids, to encourage the development of abuse-deterrent formulations, to require a study and report on policy changes that may have contributed to the opioid epidemic, and for other purposes.
Administrative law and regulatory proceduresCongressional oversightDrug, alcohol, tobacco useDrug trafficking and controlled substancesGovernment studies and investigationsHealth care coverage and accessHealth programs administration and fundingPrescription drugsState and local government operations

To require a study and report on policy and regulatory changes that may have contributed to the opioid epidemic.

USA115th CongressHR-5914| House 
| Updated: 5/22/2018
This bill requires the Government Accountability Office to report on health care policy changes that may have contributed to the rise in opioid overdoses and deaths over the last 10 years. The report must include an examination of: federal decisions relating to pain management strategies, state prescription drug monitoring programs, prescribing limitations, and pain medications with and without abuse-deterrent formulations.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 22, 2018
Introduced in House
May 22, 2018
Referred to the House Committee on Energy and Commerce.
  • May 22, 2018
    Introduced in House


  • May 22, 2018
    Referred to the House Committee on Energy and Commerce.
Mark Meadows

Mark Meadows

Republican Representative

North Carolina

Energy and Commerce Committee

Health

Related Bills

  • HR 115-4482: To deter opioid abuse and addiction, to establish additional registration requirements for prescribers of opioids, to encourage the development of abuse-deterrent formulations, to require a study and report on policy changes that may have contributed to the opioid epidemic, and for other purposes.
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresCongressional oversightDrug, alcohol, tobacco useDrug trafficking and controlled substancesGovernment studies and investigationsHealth care coverage and accessHealth programs administration and fundingPrescription drugsState and local government operations